RECURSION PHARMACEUTICALS INC. - CLASS A COMMON S
5.5800
30-四月-25 15:47:51
15 分钟延时
股票
-0.1400
-2.45%
今日范围
5.2400 - 5.6300
ISIN
N/A
来源
NASDAQ
-
Recursion Appoints Najat Khan, PhD, as Chief R&D Officer and Chief Commercial Officer
16 4月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Recursion to Participate in Upcoming Investor Conference
02 4月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Recursion Publishes Annual Environmental, Social and Governance Report
26 3月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
Recursion Announces Plans to Open New Office in London
11 3月 2024 03:00:00 条件 Nasdaq GlobeNewswire
-
Recursion Hosts Second Annual Rare Disease Day Events for Utah’s Rare Disease Community
01 3月 2024 13:58:00 条件 Nasdaq GlobeNewswire
-
Recursion to Participate in Upcoming Investor Conferences
01 3月 2024 06:59:00 条件 Nasdaq GlobeNewswire
-
27 2月 2024 15:05:11 条件 Nasdaq GlobeNewswire
-
Recursion to Host Public L(earnings) Call on February 27
20 2月 2024 06:59:00 条件 Nasdaq GlobeNewswire
-
Altitude Lab Startups Raise Over $120M in Capital
24 1月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
Recursion Unveils LOWE Drug Discovery Software at the J.P. Morgan Healthcare Conference
08 1月 2024 09:59:00 条件 Nasdaq GlobeNewswire
-
Recursion Adds New Chemical Entity Targeting Fibrotic Diseases to Late Discovery Pipeline
04 1月 2024 06:59:00 条件 Nasdaq GlobeNewswire
-
Recursion to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 8
03 1月 2024 07:00:00 条件 Nasdaq GlobeNewswire
-
20 12月 2023 06:59:00 条件 Nasdaq GlobeNewswire
-
Bayer and Recursion Focus Research Collaboration on Oncology
09 11月 2023 08:41:30 条件 Nasdaq GlobeNewswire
-
09 11月 2023 07:01:00 条件 Nasdaq GlobeNewswire
-
Recursion Provides Business Updates and Reports Third Quarter 2023 Financial Results
09 11月 2023 06:58:00 条件 Nasdaq GlobeNewswire
-
Recursion to Participate in Upcoming Investor Conference
02 11月 2023 07:05:00 条件 Nasdaq GlobeNewswire
-
Recursion to Participate in Upcoming Investor Conferences
05 9月 2023 15:30:00 条件 Nasdaq GlobeNewswire
-
Recursion Announces Completion of Phase 1 Study for REC-3964 for Clostridioides Difficile Infection
05 9月 2023 06:59:00 条件 Nasdaq GlobeNewswire
-
08 8月 2023 07:00:01 条件 Nasdaq GlobeNewswire